BIOSW (BioPlus Acquisition) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOSW BioPlus Acquisition Corp BIOSW
21 GF Score
Price $0.00
View Full Analysis

What is BioPlus Acquisition Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BIOSW
21GF Score
BioPlus Acquisition Corp BIOSW
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioPlus Acquisition Business Description

Address 260 Madison Avenue, Suite 800, New York, NY, USA, 10026
BioPlus Acquisition Corp is a blank check company.
21GF Score

Get the complete analysis for BIOSW

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price